End-to-End Program
Altasciences' Proactive Drug Development Solution: Small Molecules
Reduce Your Drug Development Costs and Delays
Benefit from Partnering with a Single CRO/CDMO Partner―From Formulation to Preclinical to Clinical
The drug development journey often involves working with different CRO and CDMO partners. But there’s a simpler, more efficient solution!
Altasciences’ fully integrated, end-to-end offering means seamless transition from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This reduces complex handoffs, communication errors, and delays.
Discover how we support you through each phase of your drug development.
![Video - Manufacturing & Analytical Services](/sites/default/files/inline-images/CDMO-Services-Video-Thumbnail.jpg)
Related pages:
- Webpage: Formulation, Development, and Manufacturing Solutions
- Virtual Tour: Manufacturing Facility and Analytical Laboratories
- Webinar: Overcoming Challenges of Manufacturing in Clinical Trials
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
Accelerate the Development of Your CNS-Active Drugs with Pharmacodynamic Measures
Accelerate the Development of Your CNS-Active Drugs with Pharmacodynamic Measures
Strategic design and targeted use of pharmacodynamic measures can greatly assist in evaluating the safety and potential efficacy of your new drug candidate in the early stages of clinical development.
In this on-demand webinar, our experts discuss how to include validated models of pain, anxiety, and other psychiatric conditions as part of a battery of tests for cognition and safety, to evaluate a drug’s potential for abuse or dependence, as well as its ability to enhance or impair performance.
![Webinar - Inside the Pharmacodynamic Toolbox](/sites/default/files/inline-images/email_Webinar-Pharmacodynamic-Toolbox.jpg)
You may also be interested in the following:
- The Altascientist: Considerations for Your CNS-active Drug Development Program
- Webinar — Assessing Cognition and Driving Ability in Clinical Pharmacology Studies
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programmes, to offer an integrated/synchronized approach to CRO and CDMO services.
Clinical Research… Beyond the Trial
Comprehensive Clinical Research Support
A successful clinical trial is more than just conduct. A complete suite of integrated, research support services and expert scientific input are key to reaching your study goals.
Enhance your drug development program with Altasciences’ research support services, whether as stand-alone offerings or as part of a complete program. Your chosen partners become ours, and we act as integral contributors, applying decades of knowledge and expertise, and moving in unison to deliver the highest quality results.
Let us know how we can support you!
Have five minutes? Take a look at these:
- Fact Sheet: Comprehensive Research Support Offering
- Webpage: Research Support Capabilities
- eBook: One Integrated Solution for Your Preclinical to Clinical Drug Development Needs
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services.
Real-World Insights from Biopharma Exec Survey — Selecting the Right CRO
One-Stop Solution for Meeting Your Needs in Outsourcing Drug Development
Altasciences recently conducted a survey to understand the challenges biopharmaceutical companies face when outsourcing their early phase drug development programs. Over 143 executives shared the important factors that guide them in the selection of a CRO partner.
Their candid testimonials are shared in this playbook, including:
- The significant challenges encountered when conducting preclinical and Phase I studies
- The unique difficulties of transitioning from preclinical to first-in-human studies
- The specific capabilities and expertise executives look for in their CRO partners
- The novel drug development solution approach for addressing the challenges encountered
Download your copy today.
![One Integrated Solution for Meeting Your Preclinical to Clinical Drug Development Needs](/sites/default/files/inline-images/Thumbnail_Biopharma_Dive_Playbook_One_Intergrated_Solution.png)
Let us help! Speak with our experts today.
You may also be interested in the following:
Webpages:
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
Seamless Bioanalytical Transition from Preclinical to Clinical, and Beyond
Seamless Bioanalytical Transition
Altasciences’ scientists move in unison with you, collaboratively, accurately, and efficiently, from preclinical to clinical, and beyond. Our team of over 260 bioanalytical scientific veterans is strategically located across North America, and has experience with a wide spectrum of biological matrices in both animal and humans.
Driven by your assay requirements, our program support includes LC-MS/MS, LBA OR HYBRID LBA/LC-MS/MS ASSAY platforms for:
|
|
Have 5 minutes? You may also be interested in the following:
- Assay List — Over 685 Assays covering 650 Molecules
- The Altascientist — Validation of Immunogenicity Assays
- Webinar — Development of a Cell-Based Assay for Dual Purposes: to Support Drug Potency and Immunogenicity Characterization
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services.
One Integrated Solution for Meeting Your Preclinical to Clinical Drug Development Needs
Your Partner in Drug Development
Moving in Unison to Bring Your Vision to Life
Trust is an important factor in any relationship. And we know trust is earned.
That’s why at Altasciences, our focus is on you. We build strong relationships with each client through quality science and proactive, responsive, and transparent communication that ensures you only have to Tell Us Once™.
When you choose us, you are choosing a partner that will work as an extension of your team — who treats you like colleagues and your projects as our own. We’ll work side by side, getting to know your goals and understanding your needs. From preclinical to clinical proof of concept, and beyond, we’ll advance your molecule in one integrated, seamless process, celebrating your milestones together.
Why? Because drug development isn’t a transaction — it’s a journey. Speak with an Altasciences expert to start your journey.
Watch this video to discover what it means to partner with Altasciences:
![Video - Inspiration Starts with You](/sites/default/files/inline-images/video_inspiration-start-with-you.png)
Have five minutes? Take a look at these:
- Check out our new interactive brochure
- Discover our Proactive Drug Development solution
- Read this blog article: Moving Your Drug Forward to Preclinical Trials
- Explore our customizable and flexible early phase solution offering
- Read this Q&A featuring Marie-Hélène Raigneau, our Co-Chief Operating Officer
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
A Solution to Drive Your Drug Development Forward
Nonclinical and Clinical Research Services — Phase I to IV
Whether you are looking for a full-service solution or a stand-alone offering, Altasciences will help guide you along the way. We are accustomed to managing complex projects with different partners, and have robust communication and operational processes in place to ensure efficient integration.
We offer a range of services for early phase and late phase studies, including:
- Program Management
- Clinical Monitoring
- Scientific Publication Development and Review
- Protocol Development and Medical Writing
- PK/PD Analysis and Interpretation
- Data Management
- Biostatistics and Statistical Analysis
- Support Services for Non-Clinical Studies
Have 5 minutes? You may be interested in this:
- Clinical Trial Services
- Podcast — Choosing the Right CRO for Your Clinical Trial Monitoring
- Blog — Five Things You Need to Know About Partnering with an Integrated CRO/CDMO
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.